Activist Moves & Impressive IPOs: A Dynamic Week in Life Sciences and Biotech
Published on: Aug. 12, 2025, 2:28 a.m. | Source: Devdiscourse
This week in health news, activist investor Engine Capital urges Avantor's board overhaul, China's Ab&B Bio-Tech IPO sees remarkable success, Novo Nordisk pursues legal battles over Wegovy copies, and IO Biotech's cancer vaccine trial reveals promising yet statistically insignificant results. Fire in France and China's poultry import ban make headlines.
